US Stock Futures Gain Ahead Of Economic Data
US stock futures traded higher in early pre-market trade. The S&P/Case-Shiller home price index for April will be released at 9:00 a.m. ET, while the Chicago PMI for June will be released at 9:45 a.m. ET. The Conference Board's Consumer Confidence Index for June will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 67.5 points to 17,587.5, while the Standard & Poor's 500 index futures rose 9.95 points to 2,060.45. Futures for the Nasdaq 100 index climbed 14.70 points to 4,392.70.
A Peek Into Global Markets
European markets were mostly lower today, with the Spanish Ibex Index rising 0.13 percent, STOXX Europe 600 Index falling 0.56 percent and German DAX 30 index dropping 0.35 percent. French CAC 40 Index declined 0.40 percent and London's FTSE 100 Index fell 0.58 percent.
In Asian markets, Japan's Nikkei Stock Average rose 0.63 percent, Hong Kong's Hang Seng Index gained 1.09 percent, China's Shanghai Composite Index jumped 5.53 percent and India's BSE Sensex gained 0.49 percent.
Analysts at Deutsche Bank downgraded SYSCO Corporation (NYSE: SYY) from Buy to Hold and lowered the price target from $50.00 to $40.00.
Sysco shares fell 2.16 percent to close at $37.54 on Monday.
- Juno Therapeutics Inc (NASDAQ: JUNO) soared Monday afternoon on news that it signed a 10-year drug development pact with Celgene Corporation (NASDAQ: CELG) after the bell Monday. To read the full news, click here.
- Broadwind Energy, Inc. (NASDAQ: BWEN) today announced the extension of its $20 million credit facility with Atlanta-based AloStar Bank of Commerce. To read the full news, click here.
- Xilinx, Inc. (NASDAQ: XLNX) today announced its collaboration with China Mobile Research Institute (CMRI) for the development of the next generation fronthaul interface (NGFI) in an MOU signing ceremony during the China Mobile Research Institute hosted NGFI Workshop. To read the full news, click here.
- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) today announced the appointment of Nathalie Adda, M.D., as Senior Vice President and Chief Medical Officer, responsible for clinical and regulatory affairs. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.